Ming Kuang, Li Tan, Lixia Xu, Shun-Li Shen, Dongming Li, Yunpeng Hua, Shaoqiang Li, Lijian Liang, Qiang He, Qi Zhou, Wenxuan Xie, Zebin Chen, Jian Wu, Jiaping Li, Wenzhe Fan, Wenquan Zhuang, Lili Chen, Shiting Feng, Sui Peng, Jiping Wang. "Neoadjuvant immune-checkpoint blockade therapy in combination with TACE for resectable hepatocellular carcinoma with high recurrence risk: A phase II, single-arm clinical trial (MORNING).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16304